- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 413/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 413/06
Total number of patents in this class: 2184
10-year publication summary
|
139
|
161
|
170
|
157
|
115
|
139
|
156
|
144
|
110
|
64
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VALO Health, Inc. | 192 |
51 |
| Takeda Pharmaceutical Company Limited | 2714 |
50 |
| Merck Sharp & Dohme LLC | 3728 |
50 |
| Boehringer Ingelheim International GmbH | 4501 |
38 |
| Janssen Pharmaceutica N.V. | 3177 |
36 |
| F. Hoffmann-La Roche AG | 7832 |
34 |
| Bristol-myers Squibb Company | 4721 |
33 |
| Novartis AG | 10300 |
25 |
| Hoffmann-La Roche Inc. | 3773 |
23 |
| Achillion Pharmaceuticals, Inc. | 158 |
23 |
| Merck Patent GmbH | 5725 |
22 |
| Incyte Corporation | 1068 |
19 |
| AstraZeneca AB | 2815 |
18 |
| Pfizer Inc. | 3384 |
18 |
| Gilead Sciences, Inc. | 2219 |
18 |
| Amgen Inc. | 4425 |
15 |
| Abbvie Inc. | 1838 |
15 |
| The Regents of the University of California | 20690 |
14 |
| Syngenta Crop Protection AG | 6668 |
13 |
| Global Blood Therapeutics, Inc. | 171 |
13 |
| Other owners | 1656 |